Navigation Links
Brookdale Announces Third Quarter 2007 Results
Date:11/7/2007

Facilities Units/Beds Revenues

Owned 170 18,745 40.9%

Leased 357 28,808 58.8%

Managed 23 4,529 0.3%

Total 550 52,082 100.0%

Operating Type

Independent Living 70 12,331 24.6%

Assisted Living 409 21,086 42.6%

Retirement Centers/CCRCs 48 14,136 32.5%

Managed 23 4,529 0.3%

Total 550 52,082 100.0%

Our quarterly facility financial data for the three months ended September 30, 2007 and June 30, 2007 was as follows (in thousands, except occupancy, margin and average revenue per occupied unit/bed):

For The

Three Months Ended

Sept. 30, June 30, Increase

2007 2007 (Decrease) Percentage

Average Occupancy 90.8% 90.7% 0.1% 0.1%

Average Revenue per Occupied

Unit/Bed(1) $3,639 $3,573 $66 1.8%

Resident Fees (including

community fees)(2) $462,766 $453,390 $9,376 2.1%

Resident Fees(3) $457,779 $451,981 $5,798 1.3%

Facility Operating Expenses 294,997 285,866 9,131 3.2%

Facility Operating Income $162,782 $166,115 $(3,333) (2.0%)

Facility Operating Income

Margin 35.6% 36.8%

(1) Average revenue per occupied unit/bed represents the average of the

total monthly revenues, including communi
'/>"/>

SOURCE Brookdale Senior Living Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine news :

1. Brookdale Announces Third Quarter Common Stock Dividend of $0.50
2. Brookdale Announces Third Quarter 2007 Release and Earnings Call
3. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
4. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
5. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
6. HEI, Inc. Announces Sale of RFID Division Assets
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
9. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
10. Brooke Franchise Corporation Announces Selected July Results
11. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Eagle Ventures' Subsidiary Hydrate2O Receives '2008 Top Gear of the Year' Award From ShapeYou.com 2Health News:Eagle Ventures' Subsidiary Hydrate2O Receives '2008 Top Gear of the Year' Award From ShapeYou.com 3Health News:Eagle Ventures' Subsidiary Hydrate2O Receives '2008 Top Gear of the Year' Award From ShapeYou.com 4Health News:Osteotech Reports 2008 Second Quarter Diluted Earnings Per Share of $.10 on Revenues of $27.6 Million 2Health News:Osteotech Reports 2008 Second Quarter Diluted Earnings Per Share of $.10 on Revenues of $27.6 Million 3Health News:Osteotech Reports 2008 Second Quarter Diluted Earnings Per Share of $.10 on Revenues of $27.6 Million 4Health News:Osteotech Reports 2008 Second Quarter Diluted Earnings Per Share of $.10 on Revenues of $27.6 Million 5Health News:NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008 2Health News:NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008 3Health News:NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008 4Health News:NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008 5Health News:NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008 6Health News:NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008 7Health News:NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008 8Health News:New Website Helps Doctors and Dentists Locate Disability Insurance 2Health News:New Website Helps Doctors and Dentists Locate Disability Insurance 3Health News:Healthcare Leaders Focus on Patient-Centered Care at Annual Planetree Conference 2Health News:Healthcare Leaders Focus on Patient-Centered Care at Annual Planetree Conference 3
Breaking Medicine Technology:Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4VisEn Launches New OsteoSense 28R 29 800 and VivoTag 28R 29 800 Fluorescence Molecular Imaging Agents 6408 1VisEn Launches New OsteoSense 28R 29 800 and VivoTag 28R 29 800 Fluorescence Molecular Imaging Agents 6408 2VerifyNow 28R 29 System Highlighted in POPular Study Comparing Platelet Reactivity Tests 6404 1VerifyNow 28R 29 System Highlighted in POPular Study Comparing Platelet Reactivity Tests 6404 2Caliper Life Sciences Partners with Prestwick Chemical to Offer Customized Chemistry and Biology Programs for Drug Discovery Research 6400 1Caliper Life Sciences Partners with Prestwick Chemical to Offer Customized Chemistry and Biology Programs for Drug Discovery Research 6400 2Caliper Life Sciences Partners with Prestwick Chemical to Offer Customized Chemistry and Biology Programs for Drug Discovery Research 6400 3